Mariani, .G. et al. 2006. Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs. Farmeconomia. Health economics and therapeutic pathways. 7, 2 (Sep. 2006), 119–124. DOI:https://doi.org/10.7175/fe.v7i2.681.